A detailed history of Lowe Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lowe Wealth Advisors, LLC holds 10 shares of BMY stock, worth $568. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 10 -0.0%
Holding current value
$568
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

SELL
$57.89 - $64.73 $868 - $970
-15 Reduced 60.0%
10 $0
Q4 2021

Jan 18, 2022

SELL
$53.63 - $62.52 $6,167 - $7,189
-115 Reduced 82.14%
25 $2,000
Q1 2021

Apr 06, 2021

BUY
$59.34 - $66.74 $7,417 - $8,342
125 Added 833.33%
140 $9,000
Q4 2019

Jan 15, 2020

BUY
$49.21 - $64.19 $738 - $962
15 New
15 $1,000
Q4 2017

Jan 18, 2018

SELL
$59.94 - $65.35 $54,725 - $59,664
-913 Closed
0 $0
Q3 2017

Oct 05, 2017

BUY
$55.23 - $63.74 $50,424 - $58,194
913
913 $58,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lowe Wealth Advisors, LLC Portfolio

Follow Lowe Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Wealth Advisors, LLC with notifications on news.